Jianpi Yiqi Shexue ameliorates immune thrombocytopenia related fatigue by regulating mitochondrial function | Zendy

Yayue Zhang | Zendy; Jia Wang | Zendy; Jieyin Gao | Zendy; Ming Guo | Zendy; Haiyan Chen | Zendy; Junxia Liu | Zendy; Li Ling | Zendy; Junyao Liao | Zendy; Xinyi Chen | Zendy; Haiyan Lang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Jianpi Yiqi Shexue ameliorates immune thrombocytopenia related fatigue by regulating mitochondrial function

Author(s) -

Yayue Zhang,

Jia Wang,

Jieyin Gao,

Ming Guo,

Haiyan Chen,

Junxia Liu,

Li Ling,

Junyao Liao,

Xinyi Chen,

Haiyan Lang

Publication year - 2021

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-2153

Subject(s) - medicine , immune thrombocytopenia , immune system , platelet , cardiology , immunology

Immune thrombocytopenia (ITP) is a heterogeneous autoimmune disease characterized by platelet destruction. In previous studies, Jianpi Yiqi Shexue (JPYQSX) was shown to increase the peripheral platelet (PLT) counts in patients with ITP. In addition, JPYQSX also dramatically alleviated weakness and fatigue. This study aimed to investigate the effect of JPYQSX on ITP related fatigue and to illuminate the underlying mechanisms of its therapeutic effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research